Concepedia

Publication | Open Access

Safety and immunogenicity of different doses and schedules of a live attenuated tetravalent dengue vaccine (TDV) in healthy adults: A Phase 1b randomized study

DOIFull Paper Access

64

Citations

11

References

2015

Year

Richard Rupp, Gary J. Luckasen, Judith L. Kirstein, Jorge E. Osorio, Joseph D. Santangelo, Marsha G. Raanan, Mary Smith, Derek Wallace, Gilad S. Gordon, Dan T. Stinchcomb
Vaccine

Abstract

All TDV doses and dosing schedules were well tolerated and immunogenic in healthy flavivirus-naive adults (ClinicalTrials.gov NCT01511250).

References

YearCitations

Page 1